Advertisement

Stopping RAS Inhibitors May Worsen Outcomes in CKD

0

Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death

COVID-19 Infection Higher Among Support Staff Than Doctors

CDC Describes COVID-19 Trends in Nursing Home Residents, Staff

0

Rates of COVID-19 increased during June and July, followed by decline through mid-September, increase by late November

One-Dose Covid-19 Vaccine From Johnson & Johnson Looks Promising

U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day

0

News comes as Ohio State University researchers discover new variant of COVID-19 virus

B1/15 - Masks

College Campuses at Risk for Extreme Incidence of COVID-19

0

Colleges rapidly reduced the number of new infections, but many failed to control the spread beyond the campus

New Insights Into How COVID-19 Damages the Brain

Multifocal Microvascular Injury ID’d in Brain in COVID-19

0

No SARS-CoV-2 detected in postmortem samples, but brain may be susceptible to microvascular damage

Greater Levels of Exercise May Protect Brain in Later Life

0

Greater levels of moderate- to vigorous-intensity physical activity linked to more intact white matter integrity in late life, lower odds of lacunar infarcts

B 11/5 Smoking Bans May Not Guard Against Secondhand Smoke: Study

Causal Link Suggested for Smoking, Subarachnoid Hemorrhage

0

Genetic susceptibility to smoking, assessed using polygenic risk score, is associated with increased risk for SAH

More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months

0

Large clinically important improvements observed in weight loss, triglycerides, and insulin sensitivity, which decreased at 12 months

Emergency Departments Saw Decrease in All Non-COVID-19 Diagnoses

Drop in ED Visits for Cardiac Conditions Tied to Later Cardiac Deaths

0

Undertreatment of cardiac conditions during COVID-19 pandemic tied to delayed excess mortality versus previous years

La vacuna de Pfizer contra la COVID parece promisoria

Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2

0

Neutralizing antibodies detected in 90 percent or more of all participants on day 29 after the first vaccine dose